Biotech & Pharma

Premium Access for Alliance Members

AABME is a new site offering a range of professional and networking resources to bridge the gap between basic research and applied research. Join the alliance to connect with other practitioners and gain access to premium content – at no cost.

Putting the Freeze on Ice Recrystallization

New classes of molecules based on naturally occurring sugars promise to preserve cryogenically frozen cells and perhaps organs without any of the toxic side effects of current treatment.

Melissae Fellet
October 30, 2017
Surface Coatings for Biomedical Technologies

Risk of infection continues to be an issue across the healthcare arena. A Frost & Sullivan industry research study published in May 2017 reported that global revenue in the antimicrobial coating materials market stood at $700 million in 2016, and is poised to reach $1.1 billion by 2021.

October 24, 2017
Premium Access for Alliance Members

AABME is a new site offering a range of professional and networking resources to bridge the gap between basic research and applied research. Join the alliance to connect with other practitioners and gain access to premium content – at no cost.

WHITE PAPER: Nanotech Could Transform Organ Transplants

Sign up for AABME’s white paper series to receive the next white paper authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott.

October 18, 2017
WHITE PAPER: Nanotech Could Transform Organ Transplants

Sign up for AABME’s white paper series to receive the next white paper authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott.

October 18, 2017
FDA Cancer Drug Announcement Creates Critical Role for Engineers

The FDA recently announced an exciting new class of cancer drug made from a patient’s own cells, and it is clear that engineers will play a key role in fulfilling its promise.

Michael MacRae
September 18, 2017
FDA Cancer Drug Announcement Creates Critical Role for Engineers

The FDA recently announced an exciting new class of cancer drug made from a patient’s own cells, and it is clear that engineers will play a key role in fulfilling its promise.

Michael MacRae
September 18, 2017
Tapeworms Inspire Biosensor Design

Inspired by tapeworms and other organisms, researchers seeking to implant a biosensor within the small intestine are developing an implantation capsule robot that can be swallowed.

September 11, 2017
Podcast: Biologics and Biocompatible Ionic Liquids

Safe and effective ionic liquids, biocompatible with the human body, are essential for human health. Prof. Gloria Elliott, UNC-Charlotte, discusses the numerous current applications of this technology, as well as the future of this field and the implications for humanity.

September 05, 2017
Podcast: Biologics and Biocompatible Ionic Liquids

Safe and effective ionic liquids, biocompatible with the human body, are essential for human health. Prof. Gloria Elliott, UNC-Charlotte, discusses the numerous current applications of this technology, as well as the future of this field and the implications for humanity.

September 05, 2017
Podcast: How Cells Turn Rogue and Cause Cancer

Dr. Denis Wirtz discusses how cells turn rogue, escape incarceration, and become a cancer upon their surroundings.

August 30, 2017
Molecular "Slingshot" Takes Aim at Disease

A novel molecular slingshot harnesses the human immune system to fight infection with lethal precision.

Michael MacRae
August 21, 2017
Molecular "Slingshot" Takes Aim at Disease

A novel molecular slingshot harnesses the human immune system to fight infection with lethal precision.

Michael MacRae
August 21, 2017
Podcast: Connecting Students with Medical Professionals

Prof. Joel Berry, University of Alabama, Birmingham, talks about the effort to bolster undergraduate education in this podcast recorded at the 2017 SB3C Conference in Tucson, AZ.

August 21, 2017
Podcast: Capturing Circulating Tumor Cells

In a podcast recorded at the 2017 SB3C summer conference, Prof. Yaling Liu, Lehigh University, discusses his work using microfluidic devices to capture circulating tumor cells.

August 07, 2017